In 1984, Hatch-Waxman tried to balance drug innovation against availability; it was tested in the US Supreme Court in 2013.

Overall utilization of the few biosimilars currently available to patients has been limited.

The AMA Code of Medical Ethics offers guidance on stewardship and professionalism.

Closed formularies can be justified when they enable spending on other socially valuable aims, but they can single out poor patients.

Low-resource areas are heterogeneous and changing, so establishing an evidence base for decision making about technology use is an important priority.

Exploitation can be exacerbated when health professions students’ educational goals are overemphasized relative to patients’ and communities’ needs.

Regularly scheduled dialysis is not standard of care for most undocumented immigrants in the United States, so preventative care, and advocacy for it, is needed.

Inequity makes it imperative to consider how trade and patent policies influence international patients’ access to treatment and prevention.

Redirecting focus from treatment to prevention is a global public health imperative.

HPV tests are alternatives to Pap smear screening that enable women to self-collect specimens and might be the best cervical cancer prevention strategy for many.